Patient Leaflet Updated 06-Nov-2024 | Celix Pharma Ltd
Ranolazine Celix Prolonged-release Tablets
Ranolazine Celix 375 mg Prolonged-release Tablets
Ranolazine Celix 500 mg Prolonged-release Tablets
Ranolazine Celix 750 mg Prolonged-release Tablets
ranolazine
1. What Ranolazine Celix is and what it is used for
2. What you need to know before you take Ranolazine Celix
3. How to take Ranolazine Celix
4. Possible side effects
5. How to store Ranolazine Celix
6. Contents of the pack and other information
Ranolazine Celix is a medicine used in combination with other medicines to treat angina pectoris, which is a chest pain or discomfort that you feel anywhere along the upper part of your body between your neck and upper abdomen, often brought on by exercise or too much activity.
You must talk to a doctor if you do not feel better or if you feel worse.
Talk to your doctor before taking Ranolazine Celix:
Your doctor may decide to give you a lower dose or take other precautions if any of these apply to you.
Do not use the following medicines if you take this medicine:
Tell your doctor or pharmacist before you take this medicine if you use:
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
This medicine can be taken with or without food. While being treated with this medicine, you should not drink grapefruit juice.
You should not take this medicine if you are pregnant unless your doctor has advised you to do so.
You should not take this medicine if you are breast-feeding.
Ask your doctor for advice if you are breast-feeding.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
No studies on the effects of this medicine on the ability to drive and use machines have been performed. Ask your doctor for advice about driving or using machines.
This medicine may cause side effects such as dizziness (common), blurred vision (uncommon), confusional state (uncommon), hallucination (uncommon), double vision (uncommon), coordination problems (rare), that may affect your ability to drive or use machines. If you experience these symptoms, do not drive or operate machinery until they have resolved completely.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Always swallow the tablets whole with water. Do not crush, suck, or chew the tablets or break them in half, as this might affect the way the medicine is released from the tablets into your body.
The starting dose for adults is one 375 mg tablet twice a day. After 2−4 weeks, your doctor may increase the dose to get the right effect. The maximum dose of this medicine is 750 mg twice a day.
It is important that you tell your doctor if you get side effects such as dizziness or feeling or being sick. Your doctor may lower your dose or, if this is not sufficient, stop treatment with this medicine.
Children and adolescents under 18 years old should not take this medicine.
If you accidentally take too many tablets of this medicine or take a higher dose than recommended by your doctor, it is important that you tell your doctor at once. If you cannot contact your doctor, go to the nearest accident and emergency department. Take along any tablets that are left, including the container and the carton, so that the hospital staff can easily tell what you have taken.
If you forget to take a dose, take it as soon as you remember unless it is nearly time (less than 6 hours) to take your next dose. Do not take a double dose to make up for a forgotten dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You should stop taking this medicine and see your doctor immediately if you experience the following symptoms of angioedema, which is a rare condition but can be severe:
Tell your doctor if you experience common side effects such as dizziness or feeling sick or vomiting. Your doctor may lower your dose or stop treatment with this medicine.
Other side affects you may experience include the following:
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Not known (frequency cannot be estimated from the available data):
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: Website www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is ranolazine. Each tablet contains 375 mg, 500 mg and 750 mg ranolazine.
The other ingredients are: microcrystalline cellulose, lactose monohydrate, methacrylic acid-ethyl acrylate copolymer, sodium hydroxide, hypromellose, magnesium stearate.
Depending on the tablet strength, the tablet coating also contains:
Ranolazine Celix prolonged-release tablets are oblong shaped tablets.
The blisters consist of a PVC/PE/PVDC White Opaque base foil and Aluminum Lidding foil.
Ranolazine Celix tablets are supplied in cartons containing 28, 30, 56, 60 or 100 tablets in blister strip.
Not all pack-sizes may be marketed.
Marketing Authorization Holder:
Manufacturer:
or
If you are blind or partially sighted and require this leaflet in a different format, call 0800 669 6825 or contact [email protected].
This leaflet was last revised in April 2024
CEL00099
12 Constance Street, International House, London, E16 2DQ, UK
0800 669 6825
http://www.celixpharma.com/
0800 669 6825
+44 (0)203 105 6525